Order Article Reprints

Lee H, Haque S, Gupta R, Kolitz JE, Allen SL, Rai K, Chiorazzi N, Mongini PKA. BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism. Lymphatics. 2024; 2(2):50-78. https://doi.org/10.3390/lymphatics2020005

Lee, Hyunjoo, Shabirul Haque, Rashmi Gupta, Jonathan E. Kolitz, Steven L. Allen, Kanti Rai, Nicholas Chiorazzi, and Patricia K. A. Mongini. 2024. "BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism" Lymphatics 2, no. 2: 50-78. https://doi.org/10.3390/lymphatics2020005

Lee, H., Haque, S., Gupta, R., Kolitz, J. E., Allen, S. L., Rai, K., Chiorazzi, N., & Mongini, P. K. A. (2024). BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism. Lymphatics, 2(2), 50-78. https://doi.org/10.3390/lymphatics2020005